Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?


Ayan A. K., ERDEMCİ B., Orsal E., Bayraktutan Z., AKPINAR E., Topcu A., ...Daha Fazla

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.35, sa.2, ss.102-106, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.remn.2015.09.002
  • Dergi Adı: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.102-106
  • Anahtar Kelimeler: Lung cancer, Bone metastasis, Positron emission tomography, CEA, OPN, POSITRON EMISSION TOMOGRAPHY, TUMOR-MARKERS, SKELETAL METASTASES, DIAGNOSTIC-VALUE, CYFRA 21-1, OSTEOPONTIN, VARIANTS, PET/CT, ACID
  • Atatürk Üniversitesi Adresli: Evet

Özet

Objective: In this study, an evaluation was made of the relationship between the serum levels of carcinoembryonic antigen (CEA), osteopontin (OPN), and the semi-quantitative parameters of 18-fluoro2-deoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in lung cancer patients with bone metastasis.